IP Library › Granted Patent US 12,544,014
Granted Patent B2
US 12,544,014 · App. 18/425,393 · Granted Feb 10, 2026

Alert system for hypo and hyperglycemia prevention based on clinical risk

Inventors: Giovanni Sparacino (Padua, IT); Claudio Cobelli (Padua, IT); Stefania Guerra (Carre, IT); Andrea Facchinetti (Padua, IT); Michele Schiavon (Chioggia, IT)
Assignee: Dexcom, Inc.
A61B5/7275A61B5/14532A61B5/743A61B5/746G16H50/30A61B5/7405A61B5/7455
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,014
App. No.
18/425,393
Granted
Feb 10, 2026
Kind
B2
Abstract

A device for generating alerts for Hypo and Hyperglycemia Prevention from Continuous Glucose Monitoring (CGM) determines a dynamic risk based on both information of glucose level and a trend obtainable from a CGM signals. The device includes a display whose color depends on the DR (for example, red for high DR, green for low risk). When DR exceeds a certain threshold, alerts are generated to suggest the patient to pay attention to the current glucose reading and to its trend, both of which are shown on the display in numbers and symbols (e.g. an arrow with different slope or color).

Claims (35)

1 . A system for communicating glycemic risk to a patient, comprising:

a continuous glucose monitoring device that generates a series of data points indicative of a glucose level in the patient; and

processing circuitry configured to iteratively:

calculate a rate of change of the glucose level based on the series of data points;

calculate an angle that is a function of the rate of change of the glucose level;

determine a dynamic risk score based on a nonlinear transformation that converts a current glucose level and the rate of change of the glucose level to the dynamic risk score; and

display, on a user interface, information indicative of the dynamic risk score and an arrow that is angled from horizontal by the calculated angle.

2 . The system of claim 1 , wherein the processing circuitry is further configured to generate a perceptible alarm when the dynamic risk score is greater than a predetermined threshold.

3 . The system of claim 1 , wherein the processing circuitry is further configured to display, on the user interface, a color indicative of the dynamic risk score.

4 . The system of claim 3 , wherein the color is displayed as a background color.

5 . The system of claim 1 , wherein the processing circuitry is further configured to:

determine a signal to noise ratio (SNR) associated with the series of data points; and

responsive to a determination that the SNR is at a first SNR level, evaluate the rate of change of the glucose level using a first algorithm.

6 . The system of claim 5 , wherein:

the processing circuitry is further configured to, responsive to a determination that the SNR is at a second SNR level, evaluate the rate of change of the glucose level using a second algorithm; and

the first SNR level is lower than the second SNR level.

7 . The system of claim 6 , wherein the first algorithm is a regularized deconvolution algorithm.

8 . The system of claim 7 , wherein the evaluation of the rate of change using the second algorithm comprises evaluating the rate of change as first order finite differences.

9 . The system of claim 1 , wherein the display is further configured to display, on the user interface, a trend box that indicates a continuous glucose monitoring data trend.

10 . A method for communicating glycemic risk to a patient, comprising:

generating, by a continuous glucose monitoring device, a series of data points indicative of a glucose level in the patient;

iteratively calculating a rate of change of the glucose level based on the series of data points;

iteratively calculating an angle that is a function of the rate of change of the glucose level;

iteratively determining a dynamic risk score based on a nonlinear transformation that converts a current glucose level and the rate of change of the glucose level to the dynamic risk score; and

iteratively displaying, on a user interface, information indicative of the dynamic risk score and an arrow that is angled from horizontal by the calculated angle.

11 . The method of claim 10 , further comprising generating a perceptible alarm when the dynamic risk score is greater than a predetermined threshold.

12 . The method of claim 10 , further comprising displaying, on the user interface, a color indicative of the dynamic risk score.

13 . The method of claim 12 , wherein the color is displayed as a background color.

14 . The method of claim 10 , further comprising:

determining a signal to noise ratio (SNR) associated with the series of data points; and

responsive to a determination that the SNR is at a first SNR level, evaluating the rate of change of the glucose level using a first algorithm.

15 . The method of claim 14 , further comprising, responsive to a determination that the SNR is at a second SNR level, evaluating the rate of change of the glucose level using a second algorithm, wherein the first SNR level is lower than the second SNR level.

16 . The method of claim 15 , wherein the first algorithm is a regularized deconvolution algorithm.

17 . The method of claim 16 , wherein the evaluating the rate of change using the second algorithm comprises evaluating the rate of change as first order finite differences.

18 . The method of claim 10 , further comprising displaying, on the user interface, a trend box that indicates a continuous glucose monitoring data trend.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2025
From: SPARACINO, GIOVANNI; COBELLI, CLAUDIO; GUERRA, STEFANIA; FACCHINETTI, ANDREA; SCHIAVON, MICHELE
To: UNIVERSITA DEGLI STUDI DI PADOVA
Reel/Frame 072967/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2025
From: UNIVERSITY OF PADOVA
To: DEXCOM, INC.
Reel/Frame 072967/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2024
From: SPARACINO, GIOVANNI; COBELLI, CLAUDIO; GUERRA, STEFANIA; FACCHINETTI, ANDREA; SCHIAVON, MICHELE
To: DEXCOM, INC.
Reel/Frame 069335/0073 →
Continuity (6)
Continuation 17808377 · Jun 23, 2022
Continuation 16427100 · May 30, 2019
Continuation 15239712 · Aug 17, 2016
Continuation 13661393 · Oct 26, 2012
Provisional Application 61551773 · Oct 26, 2011
Related Publication 20240188899A1 · Jun 13, 2024
References Cited (20)
US 6175752B1 · Say et al. · 2001 [cited by applicant]
US 9439602B2 · Sparacino et al. · 2016 [cited by applicant]
US 10357207B2 · Sparacino et al. · 2019 [cited by applicant]
US 20050043598A1 · Goode et al. · 2005 [cited by applicant]
US 20070032706A1 · Kamath et al. · 2007 [cited by applicant]
US 20080255438A1 · Saidara · 2008 [cited by examiner]
US 20100179409A1 · Kamath et al. · 2010 [cited by applicant]
US 20110077490A1 · Simpson et al. · 2011 [cited by applicant]
US 20110077494A1 · Doniger et al. · 2011 [cited by applicant]
US 20110193704A1 · Harper · 2011 [cited by examiner]
US 20110201911A1 · Johnson et al. · 2011 [cited by applicant]
US 20120046606A1 · Arefieg · 2012 [cited by examiner]
US 20130109944A1 · Sparacino et al. · 2013 [cited by applicant]
US 20160361028A1 · Sparacino et al. · 2016 [cited by applicant]
US 20190274636A1 · Sparacino et al. · 2019 [cited by applicant]
Kovatchev, Boris P., et al. “Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.” Diabetes technology & therapeutics 7.6 (2005): 849-862… [cited by examiner]
Facchinetti, Andrea, Giovanni Sparacino, and Claudio Cobelli. “An online self-tunable method to denoise CGM sensor data.” IEEE Transactions on Biomedical Engineering 57.3 (2009): 634-641. (Year: 2009). [cited by examiner]
Facchinetti et al., “Reconstruction of Glucose in Plasma from Interstitial Fluid Continuous Glucose Monitoring Data: Role of Sensor Calibration,” Journal of Diabetes Science and Technology, vol. 1(5), Sep. 2007, pp. 617… [cited by applicant]
Sparacino G., et al., “Winstodec: a stochastic deconvolution interactive program for physiological and pharmacokinetic systems,” Computer Methods and Programs in Biomedicine, 2001, vol. 67 , pp. 67-77. [cited by applicant]
Vicini P., et al., “Estimation of Endogenous Glucose Production after a Glucose Perturbation by Nonparametric stochastic Deconvolution,” Computer Methods and Programs in Biomedicine, 1997, vol. 52, pp. 147-156. [cited by applicant]